Skin classification, stage of disease, elevated LDH, advanced age and comorbidities, race, male sex, peripheral eosinophilia, large cell transformation, and folliculotropic MF have each been associated with poor prognosis and have been variably compiled into validated prognostic indices including the CTCL Severity Index (CTCL-SI), the Cutaneous Lymphoma International Prognostic Index (CLIPi), and the CLIC Prognostic Index.